Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer. - Chen J; Huang H; Zhong P; Lu Z; Ding X; Peng S; Zhu X; Wang F; Kong P; Tan AC; Song T; Xiao F; et al. (Journal of thoracic disease, 2025)